Imiquimod API is a pharmaceutical-grade immune response modifier and Toll-Like Receptor 7 (TLR7) agonist used in the treatment of various dermatological conditions. It stimulates the innate and adaptive immune system by inducing the production of interferon-alpha, tumor necrosis factor-alpha (TNF-α), and other cytokines that help eliminate virus-infected and abnormal cells.
Imiquimod is widely formulated into topical cream formulations for the treatment of external genital and perianal warts, actinic keratosis, and superficial basal cell carcinoma. It is recognized for its antiviral, antitumor, and immunomodulatory properties.
Manufactured under WHO-GMP-certified facilities, our Imiquimod API delivers exceptional purity, stability, and batch-to-batch consistency. Every batch undergoes stringent quality testing and is supplied with complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Imiquimod API is used in topical pharmaceutical formulations for the treatment of external genital warts, actinic keratosis, and superficial basal cell carcinoma.
Imiquimod activates Toll-Like Receptor 7 (TLR7), stimulating immune cells to produce cytokines that enhance antiviral and antitumor immune responses.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Imiquimod API in commercial quantities with worldwide export support.